Antrochoanal polyps (APs) are benign lesions originating from the mucosa of the maxillary sinus and capable of extending to the choana and nasopharynx [1]. Although the first case was reported by Palfyn in 1753, it was first described in detail by Killian [2,3]. APs constitute 4-6% of adult polyps and 33% of childhood polyps. The most common symptom is unilateral nasal obstruction. Other sympto...

Fibroepithelial polyp (FEP) is a benign tumor of mesodermal origin, which mostly found on the skin. FEPs in upper respiratory system are reported originating from oropharynx and larynx, rarely nasal cavity. A 57-year-old female presented with polyp-like lesion right septal mucosa adjacent to mucocutaneous junction. The mass was surgically removed, diagnosis FEP made based histopathological revi...

5 Correspondence: Roxana Duda 1 Calistrat Grozovici Str., 2 District, Bucharest, Romania e-mail: [email protected] Abstract. Introduction. Chronic rhinosinusitis with nasal polyposis is an important and complex disease characterized by a persistent inflammatory process involving the sinonasal mucosa, representing a serious health problem and economic challenge, with pathogenic mechanisms st...

This review describes the epidemiology and various treatments in chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP). Evidence for short-term use of systemic corticosteroids has been shown to be favorable in CRSwNP, but still limited in CRSsNP. Topical corticosteroids improve symptom scores in both CRS subgroups. The role of microbes in CRS is still con...

OBJECTIVES/HYPOTHESIS The efficacy of macrolides in chronic rhinosinusitis (CRS) is still under controversy. To date, only two double-blind, placebo-controlled studies have been published with differing results. None of these studies investigated the possible benefit of macrolides in the postoperative period. We conducted an investigator-initiated clinical trial using 250-mg erythromycin once a...